<th id="grzca"></th>
<b id="grzca"><menuitem id="grzca"></menuitem></b>

<th id="grzca"></th>
<strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    全國服務(wù)咨詢熱線:

    18438616290

    Products產(chǎn)品中心
    首頁 > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47027494Sparfloxacin 110871-86-8

    Sparfloxacin 110871-86-8

    簡要描述:Sparfloxacin 110871-86-8
    Sparfloxacin is a fluoroquinolone antibiotic used in the treatment of bacterial infections.

    • 產(chǎn)品型號:abs47027494
    • 廠商性質(zhì):生產(chǎn)廠家
    • 更新時間:2025-12-16
    • 訪  問  量:754

    詳細(xì)介紹

    品牌absinCAS110871-86-8
    分子式C19H22F2N4O3純度99%
    分子量392.4貨號abs47027494
    規(guī)格100mg供貨周期現(xiàn)貨
    主要用途used in the treatment of bacterial infec應(yīng)用領(lǐng)域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

    Sparfloxacin 110871-86-8

    產(chǎn)品描述
    描述

    Sparfloxacin is a fluoroquinolone antibiotic used in the treatment of bacterial infections. Sparfloxacin exerts its antibacterial activity by inhibiting DNA gyrase, a bacterial topoisomerase. DNA gyrase is an essential enzyme which controls DNA topology and assists in DNA replication, repair, deactivation, and transcription.

    純度
    99%
    儲存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    別名
    司帕sha星
    外觀
    黃色結(jié)晶性粉末
    可溶性/溶解性
    DMSO : 9 mg/mL (22.93 mM)
    生物活性
    In vitro(體外研究)
    Sparfloxacin shows broad and potent antibacterial activity. Its MICs for 90% of the strains tested are 0.1 to 0.78 μg/ml against gram-positive organisms, such as members of the genera Staphylococcus , Streptococcus and Enterococcus , and 0.0125 to 1.56 μg/ml against gram-negative organisms, such as members of the family Enterobacteriaceae and the genera Pseudomona . Its MICs are 0.025 to 0.78 μg/ml against glucose nonfermenters, 0.2 to 0.78 μg/ml against anaerobes, 0.0125 to 0.05 μg/ml against Legionella . Sparfloxacin targets DNA gyrase and inhibits DNA synthesis.
    In vivo(體內(nèi)研究)
    Sparfloxacin showed good oral efficacy against systemic infections with Staphylococcus aureus , Streptococcus pyogenes , Streptococcus pneumoniae , Escherichia coli , and Pseudomonas aeruginosa in mice.
    參考文獻(xiàn)
    參考文獻(xiàn)
    • 1. Schmitz FJ, et al. J Antimicrob Chemother. 1998 Apr;41(4):481-4.

    • 2. Ohashi R, et al. J Pharmacol Exp Ther. 1999 Nov;291(2):778-84.

    • 3. Oyamada Y, et al. J Med Microbiol. 2006 Jun; 55(Pt 6):729-36.

    • 4. Pan XS, et al. Antimicrob Agents Chemother. 2001 Nov; 45(11):3140-7.

    研究領(lǐng)域
    研究領(lǐng)域
    Drug DiscoverySmall Molecule DrugLead Compound Discovery
    Sparfloxacin 110871-86-8溫馨提示:本產(chǎn)品僅作科研實驗使用,不支持臨床等研究

    產(chǎn)品咨詢

    留言框

    • 產(chǎn)品:

    • 您的單位:

    • 您的姓名:

    • 聯(lián)系電話:

    • 常用郵箱:

    • 省份:

    • 詳細(xì)地址:

    • 補(bǔ)充說明:

    • 驗證碼:

      請輸入計算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
    愛必信(上海)生物科技有限公司
    地址:上海市浦東新區(qū)新浩路58號申江科創(chuàng)園18棟
    傳真:
    關(guān)注我們
    歡迎您關(guān)注我們的微信公眾號了解更多信息:
    歡迎您關(guān)注我們的微信公眾號
    了解更多信息
    <th id="grzca"></th>
    <b id="grzca"><menuitem id="grzca"></menuitem></b>

    <th id="grzca"></th>
    <strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    无码人妻一区二区三区四区老鸭窝 | 精品视频日韩 | 欧美后门菊门交3p视频 | 日韩在线黄色大片 | 综合一和综合二图片小说 |